Assistant Member, Human Oncology & Pathogenesis Program; Assistant Attending, Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center
Dr. Andrew Intlekofer is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 8 years. He is one of 463 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 50 publications and over 500 citings.
Office
Memorial Sloan Kettering Cancer Center New York 1275 York Avenue New York, NY 10021
Elisa Benedetti, Eric Minwei Liu, Cerise Tang, Fengshen Kuo, Mustafa Buyukozkan, Tricia Park, Jinsung Park, Fabian Correa, A Ari Hakimi, Andrew M Intlekofer, Jan Krums...> ;Nature Metabolism. 2023 Jun 1
Robert Stuver, Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip C Caron, Ahmet Dogan, Zachary D Epstein-Peterson, Lorenzo Falchi, Paul A Hamlin,...> ;Blood Advances. 2023 Sep 12
William T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, Alison J Moskowitz, Robert N Stuver, Catherine R Maccaro, Natasha Galasso, Tiffany Chang, Niloufer Khan...> ;Blood Advances. 2023 Sep 12
Ian Ganly, Eric Minwei Liu, Fengshen Kuo, Vladimir Makarov, Yiyu Dong, Jinsung Park, Yongxing Gong, Alexander N Gorelick, Jeffrey A Knauf, Elisa Benedetti, Jacqueline ...> ;Science Advances. 2022 Jun 24
Colin P Tang, Owen Clark, John R Ferrarone, Carl Campos, Alshad S Lalani, John D Chodera, Andrew M Intlekofer, Olivier Elemento, Ingo K Mellinghoff> ;Nature Chemical Biology. 2022 Feb 1
Ritika Kundra, Hongxin Zhang, Robert L. Sheridan, Sahussapont Joseph Sirintrapun, Avery Wang, Angelica Ochoa, Manda Wilson, Benjamin Gross, Yichao Sun, Ramyasree Madup...> ;JCO Clinical Cancer Informatics. 2021 Feb 1
Clarissa Campbell, François Marchildon, Anthony J. Michaels, Naofumi Takemoto, Joris van der Veeken, Michail Schizas, Yuri Pritykin, Christina S. Leslie, Andrew M. Int...> ;Proceedings of the National Academy of Sciences of the United States of America. 2020 Dec 29
Benjamin A. Nacev, Kevin B. Jones, Andrew M. Intlekofer, Jamie S.E. Yu, C. David Allis, William D. Tap, Marc Ladanyi, Torsten O. Nielsen> ;Nature Reviews. Cancer. 2020 Aug 11
Molly C. Kingsley, Hongbo Xie, Bo-Rui Chen, Simone S. Riedel, Taylor Pastuer, Madelyn K. Bollig, Tyler Shank, Clara Libbrecht, Sally P. Stabler, Aniruddha J. Deshpande...> ;Blood Advances. 2020 Jul 14
Hanumantha Rao Madala, Iiro Taneli Helenius, Wen Zhou, Evanna L. Mills, Yiyun Zhang, Yan Liu, Ana M. Metelo, Michelle L. Kelley, Surendra R. Punganuru, Kyung Bo Kim, B...> ;Cancer Research. 2020 Sep 1
Akihide Yoshimi, Kuan-Ting Lin, Daniel H. Wiseman, Mohammad Alinoor Rahman, Alessandro Pastore, Stanley Chun-Wei Lee, Jean Baptiste Micol, Xiao Jing Zhang, Stéphane de...> ;Nature. 2019 Oct 2
Andrew M. Intlekofer, Alan H. Shih, Abbas Nazir, Ariën S. Rustenburg, Steven K. Albanese, Minal Patel, Christopher Famulare, Fabian Correa, Naofumi Takemoto, Vidushi D...> ;Nature. 2018 Jun 27
Andrew M. Intlekofer, Erel Joffe, Connie L Batlevi, Patrick Hilden, Jie He, Venkatraman E. Seshan, Andrew D. Zelenetz, M. Lia Palomba, Craig H. Moskowitz, Carol S. Por...> ;Blood Cancer Journal. 2018 Jun 12
Natalya N. Pavlova, Sheng Hui, Jonathan M. Ghergurovich, Jing Fan, Andrew M. Intlekofer, Richard M. White, Joshua D. Rabinowitz, Craig B. Thompson, Ji Zhang> ;Cell Metabolism. 2018 Feb 6
McKenney, A., Lau, A., Somasundara, A., Spitzer, B., Intlekofer, A., Ahn, J., Shank, K., Rapaport, F., Patel, M., Papalexi, E., Shih, A., Chiu, A., Freinkman, E., Akba...> ;The Journal of Clinical Investigation. 2018 Feb 1
Anna Sophia McKenney, Allison N. Lau, Amritha Varshini Hanasoge Somasundara, Barbara Spitzer, Andrew M. Intlekofer, Jihae Ahn, Kaitlyn Shank, Franck Rapaport, Minal Pa...> ;The Journal of Clinical Investigation. 2018 Feb 1
Acquired Resistance to IDH Inhibition Through Trans or Cis Dimer-Interface Mutations
Martin S Tallman, Eytan M Stein, Alan H Shih, Maria E Arcila, Andrew M Intlekofer, Craig B Thompson, Mikhail Roshal, Nature
Abstracts/Posters
High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...
Andrew M. Intlekofer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
Andrew M. Intlekofer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019